Comparative Evaluation of Median Versus Youden Index Dichotomization Methods: Exposure-Response Analysis of Mycophenolic Acid and Acyl-Glucuronide Metabolite
- PMID: 30879263
- PMCID: PMC8516097
- DOI: 10.1007/s13318-019-00550-2
Comparative Evaluation of Median Versus Youden Index Dichotomization Methods: Exposure-Response Analysis of Mycophenolic Acid and Acyl-Glucuronide Metabolite
Abstract
Background and objectives: Dichotomization of pharmacokinetic exposure measures in exposure-response relationship studies provides results that are interpretable in clinical care. Several methods exist in the literature on how to define the cut-off values needed for the dichotomization process. Commonly, the sample median is utilized to define the dichotomizing value; however, statistical methods based on the exposure metric and its association with the outcome are argued to result in a more proper definition of the optimal cut-point. The Youden index is a recommended statistical method to define the cut-off value. The current analysis objective is to compare the dichotomization results based on the Youden index versus median methods.
Methods: Utilizing mycophenolic acid (MPA) exposure data and its related acute rejection and leukopenia outcome variables, the current study compared the MPA exposure-response relationship outcomes when MPA exposure is dichotomized via the Youden index versus median methods. Univariate logistic models were utilized to quantify the relationships between MPA exposure, including total MPA, unbound MPA, and the acyl-glucuronide metabolite of MPA, and the probabilities of acute rejection and leukopenia.
Results: The overall trend of the results of the logistic models demonstrated a general similarity in the inferred exposure-response associations when considering either the Youden index-based or the median-based dichotomization methods.
Conclusion: The results demonstrated in this analysis suggest that both the Youden index and the median methods provide similar conclusions when dichotomization of a continuous variable is considered. However, confirmation of these conclusions comes from future powered studies that include a larger number of subjects.
Figures


Similar articles
-
Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.Ther Drug Monit. 2002 Jun;24(3):390-9. doi: 10.1097/00007691-200206000-00011. Ther Drug Monit. 2002. PMID: 12021631 Clinical Trial.
-
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.Ther Drug Monit. 2008 Aug;30(4):439-44. doi: 10.1097/FTD.0b013e318180c709. Ther Drug Monit. 2008. PMID: 18641546 Clinical Trial.
-
Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.Ther Drug Monit. 2000 Feb;22(1):20-6. doi: 10.1097/00007691-200002000-00004. Ther Drug Monit. 2000. PMID: 10688252 Review.
-
Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro.Arch Toxicol. 2013 Feb;87(2):361-70. doi: 10.1007/s00204-012-0922-3. Epub 2012 Aug 23. Arch Toxicol. 2013. PMID: 22914985
-
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.Clin Biochem. 2001 Feb;34(1):17-22. doi: 10.1016/s0009-9120(00)00184-3. Clin Biochem. 2001. PMID: 11239510 Review.
Cited by
-
Prognostic Value of Combing Primary Tumor and Nodal Glycolytic-Volumetric Parameters of 18F-FDG PET in Patients with Non-Small Cell Lung Cancer and Regional Lymph Node Metastasis.Diagnostics (Basel). 2021 Jun 9;11(6):1065. doi: 10.3390/diagnostics11061065. Diagnostics (Basel). 2021. PMID: 34207763 Free PMC article.
-
Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.Ann Nucl Med. 2022 Mar;36(3):256-266. doi: 10.1007/s12149-021-01698-1. Epub 2021 Nov 24. Ann Nucl Med. 2022. PMID: 34817824
-
The Influence of the Home Food Environment on the Eating Behaviors, Family Meals, and Academic Achievement of Adolescents in Schools in the UAE.Int J Environ Res Public Health. 2024 Sep 6;21(9):1187. doi: 10.3390/ijerph21091187. Int J Environ Res Public Health. 2024. PMID: 39338070 Free PMC article.
-
Androgen Receptor: Clinical Importance in Breast Cancer Patients Receiving CDK 4/6 Inhibitor Treatment.Medicina (Kaunas). 2025 Aug 14;61(8):1464. doi: 10.3390/medicina61081464. Medicina (Kaunas). 2025. PMID: 40870508 Free PMC article.
-
DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer.J Oncol. 2022 Mar 29;2022:7521934. doi: 10.1155/2022/7521934. eCollection 2022. J Oncol. 2022. PMID: 35392433 Free PMC article.
References
-
- Linnet K, Brandt E. Assessing diagnostic tests once an optimal cut-off point has been selected. Clin Chem. 1986;32(7):1341–6. - PubMed
-
- MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Methods. 2002;7(1):19. - PubMed
-
- Hajian-Tilaki K. The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation. Stat Methods Med Res. 2018;27(8):2374–83. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources